Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids

E-ISSN： 1875-5992|12|3|219-225

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.3, 2012-03, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 3, 2009-03 ,pp. : 336-347

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Aspects of Natural and Modified Vinca Alkaloids

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 1, 2018-06 ,pp. : 55-70

Bentham Science Publishers

Access to resources Recommend Favorite

The Protein Kinase Inhibitor Balanol: Structure-Activity Relationships and Structure-Based Computational Studies

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 638-645

Bentham Science Publishers

Access to resources Recommend Favorite

Antimitotic Peptides and Depsipeptides

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 1, 2018-06 ,pp. : 19-53

Bentham Science Publishers

Access to resources Recommend Favorite

The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy

By Kaira Kyoichi

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite